Home Pilots Mark Cuban Cost Plus Drug Company partners with PBM EmsanaRx Pilots Mark Cuban Cost Plus Drug Company partners with PBM EmsanaRx By - December 8, 2022 48 0 Facebook Twitter Pinterest WhatsApp The collaboration will offer low-cost medications to employers and employees through a new platform dubbed EmsanaRx Plus. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Qritive, Corista tie up for digital pathology integration Pilots - March 20, 2023 0 Study: Medicare remote patient monitoring use surges during pandemic Pilots - August 11, 2022 0 Digital nutrition startup Culina Health raises $4.75M Pilots - May 31, 2022 0 Clinical workflow platform Florence launches with $20M Pilots - March 30, 2023 0 Penumbra, Veterans Health Administration partner to create VR-based therapeutics Pilots - April 5, 2023 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3